Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,831,393
+$413,298 QoQ
Shares Held
18,865
+3.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#689
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $104,508,931 across 9 Drug Manufacturers - General names. AMGN ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,524 | $33,013,114 | |
| 2 | JNJ |
Johnson & Johnson
|
85,199 | $21,637,990 | |
| 3 | ABBV |
AbbVie Inc.
|
61,181 | $15,395,586 | |
| 4 | MRK |
Merck & Co., Inc.
|
93,774 | $12,049,959 | |
| 5 | AMGN |
Amgen Inc
This page
|
18,865 | $6,831,393 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,580 | $5,505,897 | |
| 7 | PFE |
Pfizer Inc
|
197,099 | $4,746,143 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
72,834 | $4,196,695 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,831,393 | 18,865 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,418,095 | 18,241 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,979,953 | 18,270 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,378,732 | 19,060 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,271,205 | 18,879 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,845,301 | 18,762 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,823,664 | 18,507 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $6,042,726 | 18,754 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $5,740,956 | 18,374 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $5,621,859 | 19,773 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,508,094 | 19,124 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,123,909 | 19,065 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $3,890,456 | 17,523 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $3,761,146 | 15,558 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $3,907,557 | 14,878 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $3,118,859 | 13,837 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,861,208 | 11,760 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,698,469 | 11,159 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $2,248,575 | 9,995 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,579,564 | 7,428 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,492,725 | 6,124 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,523,712 | 6,124 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,408,030 | 6,124 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,300,282 | 5,116 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $972,214 | 4,122 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $736,923 | 3,635 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||